World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
25895
World Ranking
8457
National Ranking
3805

Khandan Keyomarsi publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Khandan Keyomarsi sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 231 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Khandan Keyomarsi D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Khandan Keyomarsi sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 66 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Khandan Keyomarsi is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans multiple disciplines, primarily within Medicine and Biochemistry, Genetics, and Molecular Biology, with a significant focus on Oncology and Pulmonary and Respiratory Medicine.

The main topics of Keyomarsi's work include:

  • Advanced Breast Cancer Therapies
  • Cancer-related Molecular Pathways
  • HER2/EGFR in Cancer Research
  • Microtubule and mitosis dynamics
  • Cancer Genomics and Diagnostics
  • DNA Repair Mechanisms
  • Cancer Cells and Metastasis

Their frequent publication venues demonstrate a concentration in cancer-related research, including:

  • Cancer Research
  • Journal of Clinical Oncology
  • Cancers
  • Pharmacological Reviews
  • Clinical Cancer Research

Among recent papers authored or co-authored by Keyomarsi are:

  • "Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance" (2024) Nature Communications
  • "Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification" (2022) Journal of Clinical Oncology
  • "PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers" (2022) Expert Opinion on Investigational Drugs
  • "Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer" (2023) JAMA Oncology
  • "Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers" (2023) Cancer Research

Keyomarsi has collaborated frequently with a number of researchers, including:

  • Kelly K. Hunt
  • Tuyen Bui
  • Nicole M. Kettner
  • Debu Tripathy
  • Akshara Singareeka Raghavendra

Their scholarly output reflects an emphasis on cancer biology, molecular mechanisms underlying cancer progression, and therapeutic approaches targeting resistant and advanced breast cancers. Key areas of study integrate cell biology and molecular biology techniques to examine cancer genomics, DNA repair, and cellular pathways involved in tumor growth and resistance mechanisms.

Best Publications

  • The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

    J. Wade Harper;Guy R. Adami;Nan Wei;Khandan Keyomarsi

  • Inhibition of cyclin-dependent kinases by p21.

    J W Harper;S J Elledge;K Keyomarsi;B Dynlacht

  • Role of cell cycle in mediating sensitivity to radiotherapy.

    Timothy M. Pawlik;Khandan Keyomarsi

  • Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase

    Deanna M. Koepp;Laura K. Schaefer;Xin Ye;Khandan Keyomarsi

  • Cyclin E and Survival in Patients with Breast Cancer

    Khandan Keyomarsi;Susan L. Tucker;Thomas A. Buchholz;Matthew Callister

  • Redundant cyclin overexpression and gene amplification in breast cancer cells

    Khandan Keyomarsi;Arthur B. Pardee

  • Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.

    Khandan Keyomarsi;Larue Sandoval;Vimla Band;Arthur B. Pardee

  • Cyclin E, a Potential Prognostic Marker for Breast Cancer

    Khandan Keyomarsi;Nuala O'Leary;Gyongyi Molnar;Emma Lees

  • Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells.

    Peng Liang;Lidia Averboukh;Khandan Keyomarsi;Ruth Sager

  • Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.

    Sarah S. Bacus;Andrei V. Gudkov;Michael Lowe;Ljuba Lyass

  • Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

    Sharmila Rao;Donald C. Porter;Xiaomei Chen;Thaddeus Herliczek

  • Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines.

    S. W. Lee;C. Tomasetto;D. Paul;Khandan Keyomarsi

  • Deregulation of cyclin E in breast cancer

    K. Keyomarsi;D. Conte;W. Toyofuku;M. P. Fox

  • Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer

    Astrid M. Eder;Xiaomei Sui;Daniel G. Rosen;Laura K. Nolden

  • Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G0/G1 to S phase transition in normal and tumor cells

    Keith D. Robertson;Khandan Keyomarsi;Felicidad A. Gonzales;Mihaela Velicescu

  • An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

    Alfred I. Geller;Khandan Keyomarsi;John Bryan;John Bryan;Arthur B. Pardee

  • Expression of cytochromes P450 in human breast tissue and tumors.

    Zeqi Huang;Michael J. Fasco;Michael J. Fasco;Helen L. Figge;Khandan Keyomarsi

  • Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms.

    Donald C. Porter;Ning Zhang;Christopher Danes;Mollianne J. McGahren

  • CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

    Smruthi Vijayaraghavan;Cansu Karakas;Iman Doostan;Xian Chen

  • Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.

    Khandan K. Keyomarsi;Richard G. Moran

Frequent Co-Authors

Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center
Aysegul A. Sahin
Aysegul A. Sahin The University of Texas MD Anderson Cancer Center
Joseph A. Caruso
Joseph A. Caruso Wayne State University
Arthur B. Pardee
Arthur B. Pardee Harvard University
Susan L. Tucker
Susan L. Tucker The University of Texas MD Anderson Cancer Center
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
Laurent Meijer
Laurent Meijer Perha Pharmaceuticals
Ian O. Ellis
Ian O. Ellis University of Nottingham
Jing Wang
Jing Wang The University of Texas MD Anderson Cancer Center
Michelle Craig Barton
Michelle Craig Barton The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a career related to Biology or Biochemistry, there are several flexible online study and job options to consider in the U.S. For those who want a health-focused route, exploring fast track nutrition degree programs can get you qualified more quickly to start your career in nutrition and wellness.

Many professionals are also combining science backgrounds with business skills by pursuing a healthcare mba cost-conscious program. These online MBAs offer affordability and flexibility, making it easier to move into healthcare management or administration roles.

For those drawn to the administrative side of healthcare, understanding the differences between the ccs certification versus other credentials is essential if you plan to enter medical coding or health information management. Both certifications lead to solid job prospects and competitive salaries.

Medical coding remains a popular path for biology graduates who want remote work options and job stability. You can learn more about medical coding jobs salary, credentialing requirements, and career progression opportunities in this fast-growing field.

Best Scientists Citing Khandan Keyomarsi

Trending Scientists

Recently Published Articles